EMA recommends new methotrexate measures
The Pharmacovigilance Risk Assessment Committee initially recommended new measures in July.
Read More
Author: Anna Smith
Amgen to acquire Celgene’s Otezla
The transaction is expected to close by the end of 2019.
Read More
FDA green light for Fasenra
Currently there are no FDA-approved treatments for eosinophilic oesophagitis.
Read More
AZ bags positive results in investigational Lupus drug trial
The drug achieved a statistically-significant and clinically-meaningful reduction in disease activity.
Read More
EU approval for Tecentriq combo
The approval of the monoclonal antibody was based on results from the Phase III IMpassion130 study.
Read More- FDA approves new high dose Spinraza regimen for SMA
- Viridian reports positive results from elegrobart phase 3 trial
- Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
- Kygevvi approved in Europe as first treatment for TK2d
- Tozorakimab shows significant benefit in two major COPD trials
